Advertisement

Topics

Eurofarma gets Brazilian rights to Melinta's delafloxacin

15:40 EDT 21 Jun 2017 | Elsevier Business Intelligence

Melinta Therapeutics Inc. licensed Eurofarma Laboratorios SA rights to commercialize and distribute its delafloxacin in Brazi...

Original Article: Eurofarma gets Brazilian rights to Melinta's delafloxacin

NEXT ARTICLE

More From BioPortfolio on "Eurofarma gets Brazilian rights to Melinta's delafloxacin"

Advertisement
Quick Search
Advertisement
Advertisement